Royalty Pharma Plc (RPRX)
58.31
-0.74
(-1.25%)
USD |
NASDAQ |
Sep 15, 15:20
Royalty Pharma 1 Year Total Returns (Daily) : 65.56% for Sept. 14, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 14, 2026 | 65.56% |
| September 11, 2026 | 62.80% |
| September 10, 2026 | 65.54% |
| September 09, 2026 | 69.22% |
| September 08, 2026 | 72.53% |
| September 04, 2026 | 76.70% |
| September 03, 2026 | 77.63% |
| September 02, 2026 | 77.87% |
| September 01, 2026 | 76.57% |
| August 31, 2026 | 73.99% |
| August 28, 2026 | 74.15% |
| August 27, 2026 | 75.05% |
| August 26, 2026 | 75.10% |
| August 25, 2026 | 75.81% |
| August 24, 2026 | 72.14% |
| August 21, 2026 | 72.13% |
| August 20, 2026 | 67.45% |
| August 19, 2026 | 74.80% |
| August 18, 2026 | 69.40% |
| August 17, 2026 | 66.73% |
| August 14, 2026 | 64.66% |
| August 13, 2026 | 64.07% |
| August 12, 2026 | 68.69% |
| August 11, 2026 | 63.12% |
| August 10, 2026 | 57.57% |
| Date | Value |
|---|---|
| August 07, 2026 | 56.69% |
| August 06, 2026 | 57.57% |
| August 05, 2026 | 55.61% |
| August 04, 2026 | 55.00% |
| August 03, 2026 | 57.37% |
| July 31, 2026 | 62.19% |
| July 30, 2026 | 62.42% |
| July 29, 2026 | 62.20% |
| July 28, 2026 | 65.30% |
| July 27, 2026 | 63.60% |
| July 24, 2026 | 64.24% |
| July 23, 2026 | 67.42% |
| July 22, 2026 | 66.16% |
| July 21, 2026 | 67.39% |
| July 20, 2026 | 64.45% |
| July 17, 2026 | 67.55% |
| July 16, 2026 | 67.94% |
| July 15, 2026 | 57.55% |
| July 14, 2026 | 56.92% |
| July 13, 2026 | 60.89% |
| July 10, 2026 | 59.59% |
| July 09, 2026 | 65.06% |
| July 08, 2026 | 67.91% |
| July 07, 2026 | 65.90% |
| July 06, 2026 | 59.87% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 4.70% |
| Johnson & Johnson | 52.93% |
| Merck & Co., Inc. | 80.80% |
| Viatris, Inc. | 73.09% |
| ANI Pharmaceuticals, Inc. | -27.95% |